[1]
Bing, H. , Li, D. , He, X., Tong, J. , Wang, Y. , Ao, R. , Wang, N. , Chang, B. and Li, Y. 2022. Retrospective analysis of the efficacy and safety of rivaroxaban in the treatment of hepatic sinus obstruction syndrome caused by Gynura segetum : Rivaroxaban for Pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Community Acquired Infection. 8, (Mar. 2022). DOI:https://doi.org/10.54844/cai.2021.0013.